FDA Peptide Update: Category 2 Removals Explained When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA warning letters target marketers of unapproved weight loss drugs RAPS FDA Moves to Reevaluate Several Peptides American Med Spa Association Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review FDA and FTC Issue 13 Warning Letters to E liquid Companies for Misleadingly Marketing to Youth; FDA Investigates Underage Use of JUUL Devices The Continuum of Risk